December 1, 2011 - Making Cancer Treatment Decisions
Your order contains item(s)
View Order
Note: The free Adobe Acrobat Reader® is required to view and print Adobe PDF files, and the free Windows Media Player or RealPlayer is required to listen to the MP3 audio files.
Date: December 1, 2011
Time: 1:00 p.m. - 2:00 p.m. ET
Location: Telephone/Web
Access: Program Slides
Listen: Presentation | Q&A Session
Read: Transcript
Topics Covered
- Questions patients need to ask to make informed treatment decisions
- Benefit-and-risk issues for standard treatments and clinical trials
- Reasons for a patient to consider a clinical trial
- How clinical trials are designed and monitored
- Financial considerations related to cancer treatment
Speakers
Gail J. Roboz, MD
Director, Leukemia Program
Associate Professor of Medicine
Weill Medical College of Cornell University
New York-Presbyterian Hospital
New York, NY
Beth Patterson
President, Mission Delivery
Patient Advocate Foundation
Hampton, VA
Questions Asked by the Cancer Community
- When a patient is given a choice between two different treatment options, how is he or she supposed to decide which one will be the most beneficial?
- What are some of the questions to ask that will help in making a decision about treatment?
- Before beginning a treatment, what should be included in an informed consent?
- Are there clinical trials for relapsed conditions?
- When one goes into a clinical trial with a center of excellence, should the center be providing an ombudsman or patient advocate?
- Does Medicaid in all states cover clinical trials?
- Does the pre-existing condition insurance cover clinical trials?
- Should one start with an aggressive protocol of treatment or is it better to start out conservatively and then move to a more aggressive treatment?
- In a clinical trial, are there pharmaceutical companies that do not pay for the cost of their drugs?
- How is someone selected for a clinical trial?
- Would a previous diagnosis of hemolytic anemia, which is now under control, be an underlying concern taken into consideration before starting treatment with standard therapy?
- Once a clinical trial is completed, does the doctor, facility or sponsoring company have a requirement to inform participants of the outcome?
- Will NCI help patients who need to travel to a hospital for clinical-trial participation outside of their clinical center in Maryland?
- Does it cost money to utilize services or assistance provided by the Patient Advocate Foundation?
Sponsors and Supporters
This program was sponsored by The Leukemia & Lymphoma Society and supported by grants from Celgene Corporation and Millennium Pharmaceuticals, Inc.
